FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.43 $ 0.00 (0 %)    

Friday, 05-Jul-2024 09:37:45 EDT
QQQ $ 492.61 $ 0.87 (0.18 %)
DIA $ 392.71 $ 0.07 (0.02 %)
SPY $ 552.05 $ 0.26 (0.05 %)
TLT $ 92.29 $ 0.21 (0.22 %)
GLD $ 219.98 $ 0.47 (0.21 %)
$ 4.23
$ 4.43
$ 0.00 x 0
$ 0.00 x 0
$ 4.43 - $ 4.43
$ 3.90 - $ 55.00
110,240
na
131.7M
$ -3.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...